Instructions for Authors — Gut and Liver
Source: http://www.gutnliver.org/content/authors/instruction_for_authors.html
2025 Impact Factor ### 4.1
Indexed In : Science Citation Index Expanded (SCIE), MEDLINE,
Pubmed/Pubmed Central, Scopus, Embase, KCI, Google Scholar,
KoreaMed, and DOAJ
- Aims and ScopeGut and Liver is an international journal of gastroenterology, focusing on the gastrointestinal tract, liver, biliary tree, pancreas, motility, and neurogastroenterology. Gut and Liver delivers up-to-date, authoritative papers on both clinical and research-based topics in gastroenterology. The Journal publishes original articles, brief communications, letters to the editor, perspectives and review articles in the field of gastroenterology and hepatology. The Journal is operated by internationally renowned editorial boards and designed to provide a global opportunity to promote academic developments in the field of gastroenterology and hepatology. +MORE
- Editorial Board### Editor-in-ChiefEditor-in-Chief Yong Chan Lee Professor of Medicine Director, Gastrointestinal Research Laboratory Veterans Affairs Medical Center, Univ. California San Francisco San Francisco, USA### Honorary Editor-in-ChiefHonorary Editor-in-Chief Young S. Kim University of California San Francisco School of Medicine, San Francisco, USA ### Deputy EditorDeputy Editor C. Richard Boland University of California San Diego School of Medicine, San Diego, CA, USA Jong Pil Im Seoul National University College of Medicine, Seoul, Korea Joo Ha Hwang Stanford University School of Medicine, Stanford, CA, USA
-
Editorial Office- office@gutnliver.org +82-2-393-3344 - +82-2-393-3344
-
Articles
- Instructions for Authors
- File Download (PDF version)
- Ethical Standards
- Peer ReviewAll papers submitted to Gut and Liver are reviewed by the editorial team before being sent out for an external blind peer review; this is done to check for papers that have low priority, insufficient originality, scientific flaws, or the absence of a message of importance to the readers of the Journal. A decision on these papers is usually made within two or three weeks. ...
Differential Diagnosis of Thickened Gastric Wall between Hypertrophic Gastritis and Borrmann Type 4 Advanced Gastric CancerJun-young Seo 1,2, Do Hoon Kim1, Ji Yong Ahn1, Kee Don Choi1, Hwa Jung Kim3, Hee Kyong Na1, Jeong Hoon Lee1, Kee Wook Jung1, Ho June Song1, Gin Hyug Lee1, Hwoon-Yong Jung1Gut Liver 2024;18(6):961-969
Gallstone Dissolution Effects of Combination Therapy with n-3 Polyunsaturated Fatty Acids and Ursodeoxycholic Acid: A Randomized, Prospective, Preliminary Clinical TrialSee Young Lee 1, Sung Ill Jang1, Jae Hee Cho1, Min Young Do1, Su Yeon Lee1, Arong Choi1, Hye Sun Lee2, Juyeon Yang2, Dong Ki Lee1Gut Liver 2024;18(6):1069-1079
Challenges in and Opportunities for Electronic Health Record-Based Data Analysis and InterpretationMichelle Kang Kim 1, Carol Rouphael1, John McMichael2, Nicole Welch1,3, Srinivasan Dasarathy1,3Gut Liver 2024;18(2):201-208
Gut-Liver Axis: The Role of Intestinal Microbiota and Their Metabolites in the Progression of Metabolic Dysfunction-Associated Steatotic Liver DiseaseChao Cui 1, Shuai Gao1,2, Jingfei Shi3, Kai Wang1,2Gut Liver 2025;19(4):479-507
office@gutnliver.org +82-2-393-3344 - +82-2-393-3344 Help
- Patient consent/confidentialityAny article that contains personal medical information about an identifiable living individual requires the patient’s explicit consent before we can publish it. If consent cannot be obtained because the patient cannot be traced, then publication will be possible only if the information can be sufficiently anonymized. Anonymization means that neither the patient nor anyone else could identify the patient with certainty. A consequence of anonymization is likely to be the loss of information or evidence. If the patient is a minor but capable of understanding what is being asked, please obtain a signed form from both the patient and his or her parent or guardian. If the patient is dead, the Data Protection Act does not apply, but the authors should seek permission from a relative (as a matter of courtesy and medical ethics). Images of patientsOur policy on obtaining consent for the publication of pictures of patients is a subset of our general policy on patient confidentiality. If there is any chance that a patient may be identified from a photograph or other image or from its legend or the accompanying text, then we will need to have the patient’s written consent to publish the paper in the Journal. Images—such as X-rays, laparoscopic images, ultrasound images, pathology slides, or images of unrecognizable parts of the body—may be used without consent as long as they have been anonymized through the removal of any identifying marks, and are not accompanied by text that could reveal the patient’s identity through clinical or personal detail. An exception to the policy of needing consent for recognizable photographs of individuals is when we use photographs from picture agencies to illustrate news stories and other articles. We always cite the source of such photographs, namely, the people shown in the photographs. If we doubt that someone in a particular photograph could have given consent (for example, due to severe mental illness or a learning disability), we use discretion and avoid such images.
- Research ethics approvalGut and Liver aims to ensure that all articles published in its journals report on work that is morally acceptable; authors are expected to follow the World Association’s Helsinki Declaration guidelines ( http://www.wma.net). The research protocol for each paper must have been approved by the relevant local ethics committee; informed consent must have been obtained from all subjects (or their guardians). Authors must explicitly state that the necessary ethics committee approval has been secured for the research reported on. This fact should also be explicitly stated in the manuscript and authors should include the name and location of the approving ethics committee(s). The critical assessment of submitted papers will include ethical considerations. Where there is any doubt about research ethics approval, the Editor may request copies of the correspondence between the authors and the research ethics committee and may also contact the Chair directly.
- Scientific misconductThere are differing definitions of scientific misconduct. We deal with such problems on a case-by-case basis, following guidance produced by bodies that include the Committee on Publication Ethics (COPE) ( http://publicationethics.org/guidelines), the World Association of Medical Editors (WAME), and the International Committee of Medical Journal Editors (ICMJE). WAME gives a useful overview of the issue of misconduct, using a slightly amended version of the US Office of Research Integrity definition of scientific misconduct, and including the following behaviors: Falsification of data: this ranges from fabrication, the deceptive reporting of findings, and the omission of conflicting data to willful suppression and/or distortion of data. Plagiarism: the appropriation of the language, ideas, or thoughts of another without crediting their true source—representing them as one’s own original work. Improprieties of authorship: the improper assignment of credit, for example, by excluding others, presenting the same material in more than one publication, including individuals as authors who have not made a definite contribution to the work, and publishing or submitting multi-authored publications without the concurrence of all authors. Misappropriation of the ideas of others: an important aspect of scholarly activity is the exchange of ideas among colleagues. Scholars can acquire novel ideas from others during the process of reviewing grant applications and manuscripts. However, the improper use of such information can constitute fraud. The wholesale appropriation of such material constitutes misconduct. Violation of generally accepted research practices: this category includes serious deviation from accepted practices in proposing or carrying out research, the improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, and the improper reporting of results. Material failure to comply with legislative and regulatory requirements affecting research: this includes but is not limited to serious or substantial, repeated, and willful violations of local regulations and laws involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biological, or chemical materials. Inappropriate behavior in relation to misconduct: this includes unfounded or knowingly false accusations of misconduct, the failure to report known or suspected misconduct, the withholding of information relevant to a claim, and any kind of misconduct or retaliation against persons involved in an allegation or investigation.
- The Administration of Cases of Research Ethics ViolationThe Research Ethics Committee of Gut and Liver (hereafter, “the Committee”) reviews research ethics cases that relate to the publication of the journal and related papers (original articles, case reports, review articles and others). We take seriously all possible cases of misconduct. If an editor has concerns that a submitted article describes something that might be considered misconduct in any aspect of research, publication, or professional behavior, we may discuss the case in confidence with the Committee. When research ethics violations occur, the chair of the Committee should call a meeting immediately to review the situation, and should report the results to the Executive Committee. The Committee should keep any investigation of ethics violations confidential, and should not oppose the interests of the Journal. Upon completion of the investigation, the Committee will determine the level of punishment appropriate for the violator (author or corresponding author), based on the level of violation—the Council can prohibit publication in the Journal for a specified period of time, or exclude the violator permanently. The Council keeps a record of the investigation and the results of the ethical misconduct. If the Council confirms ethical misconduct in a paper, the Executive Committee will announce the case and withdraw the paper. If the paper has already been published in the Journal, it will be deleted from the Journal’s list of published papers; this will be announced to the members of the Gut and Liver and Korean GI communities.
All papers submitted to Gut and Liver are reviewed by the editorial team before being sent out for an external blind peer review; this is done to check for papers that have low priority, insufficient originality, scientific flaws, or the absence of a message of importance to the readers of the Journal. A decision on these papers is usually made within two or three weeks.
The remaining articles are usually sent to two reviewers. The average number of days between the date the manuscript was received and the first decision is 15. It would be very helpful if you could suggest a selection of reviewers and include their contact details. We may not always use the reviewers you recommend, but suggesting reviewers will make our reviewer database much richer; in the end, everyone will benefit. We reserve the right to return manuscripts in which no reviewers are suggested.
The final responsibility for the decision to accept or reject a paper lies with the editors. In many cases, papers may be rejected despite favorable reviews because of editorial policy or a lack of space. The editor retains the right to determine publication priorities, the style of the paper, and to request, if necessary, that the material submitted be shortened for publication.
� RSFTSTYL )d � " G u t a n d L i v e r�� ( G a s t r o e n t e r o l o g y � 2 G u t a n d L i v e r
I n s t r u c t i o n s t o A u t h o r s :
h t t p : / / w w w . g u t n l i v e r . o r g / t h e s i s / i n t r o d u c t i o n . h t m l
E d i t e d b y K i m , D a e I n .
Y o n s e i U n i v e r s i t y M e d i c a l L i b r a r y�� ! X " ( # $ % & " ( #
$ % & ! Pp q r s t �x Py z d{ , ! | , ! x Py dz d{ , ! | , ! u X} ~ � , e t a l .� � , . . . v w - - -�� ! " Pp q r s t �x Py z d{ , ! | , ! x Py dz d{ , ! | , ! u X} ~ � , e t a l .� � , . . . v w - - -�� ! # P� 8� � (� t� � � � � . ! � � � t� � � � � . ! � � � t� � � � �
�� ! � � � h� � � � � � � � t� � � �
;�� ! � � � � t� � � �
:�� ! � � � � t� � � �
.�� ! � � � � H� � 8� t� � � � � . ! � � � h� � � � � � � � �� � � � . � ! � � e d�� ! � � � t� � � � . � ! � � � � t� � � � : � ! � � � � t� � � � , � ! � � � � t� � � �
.�� ! � � � � d� � T� t� � � � � . ! � � � t� � � � � . ! � � � ��
� � � I n : � ! � , , � e d . ^ e d s . ! � � � t� � � �
��� ! � � � � �� � � � , . � V o l u m e ��� ! � � � �
� � �� � � � . � ! � � e d�� ! � � � t� � � � . � ! � � � � t� � � � : � ! � � � � t� � � � , � ! � � � � t� � � �
:�� ! � � � � t� � � �
.�� ! � � � � d� � T� t� � � � � . ! � � � t� � � � � . ! � � � ��
� � � I n : � ! � , , � e d . ^ e d s . ! � � � t� � � �
��� ! � � � � �� � � � , . � V o l u m e ��� ! � � � �
� � �� � � � . � ! � � e d�� ! � � � t� � � � . � ! � � � � t� � � � : � ! � � � � t� � � � , � ! � � � � t� � � �
:�� ! � � � � t� � � �
.�� ! � � � $ |� t� @� � � � . ! � � % ' 0� � � � & e ( ) L |� t� +� � �
;�� ! � � � |� t� "� � � , ! � � � |� t� � � � , ! � � � �� �� � � � P > , e d i t e d a n d t r a n s l a t e d b y �� ! � � � �0
,�� ! 2 1 3 �� �� � p� h� @� � � � � � A �� �� � �� t� � � � �
��� ! � � � h� @� � � � � � 4 @p q r s t �x Xy z d{ , ! | $ a n d �� ! x Xy dz d{ , ! | $ a n d �� ! u H} ~ � � � , . . . v w B $ a n d �� ! C $ a n d �� ! 5 x� � h� � P� � � � � � � � � 6 4� � �
-�� ! 7 d� � ; ! � � � � � 8 H} ~ � � � , . . . 9 : ; , ! < = > ? @
dP Q Z , ! R S p q r s t �x Xy z d{ , ! | $ a n d �� ! x Xy dz d{ , ! | $ a n d �� ! u X} ~ � , e t a l .� � , . . . v w - - -�� ! T p q r s t �x Xy z d{ , ! | $ a n d �� ! x Xy dz d{ , ! | $ a n d �� ! u X} ~ � , e t a l .� � , . . . v w - - -�� ! U V W Y � � � � � $ I b i d . ! � �� |� � � � $ I b i d .�� ! � � � � �� � � � , , � V o l u m e ��� ! � � � �
� � t� � � �
.�� ! � � � � $ I b i d . ! � � � � � �S p q r s t �x Xy z d{ , ! | $ a n d �� ! x Xy dz d{ , ! | $ a n d �� ! u X} ~ � , e t a l .� � , . . . v w - - -�� ! T p q r s t �x Xy z d{ , ! | $ a n d �� ! x Xy dz d{ , ! | $ a n d �� ! u X} ~ � , e t a l .� � , . . . v w - - -�� ! � U [ L |� t� +� � � , ! � � � |� t� "� � � , ! � � � |� t� � � � , ! � � � �� �� � � � P > , e d i t e d a n d t r a n s l a t e d b y �� ! � � � a b <d c , A n o n y m o u s�� ! ( @ A B C � � � � � � � � � � �
Proprietary Rights Notice for Gut and Liver Online
-
The person using Gut and Liver Online may use, reproduce, disseminate, or display the open access version of content from this journal for non-commercial purposes ANY USE of the open access version of this Journal in whole or in part must include the customary bibliographic citation, including author and publisher attribution, date, article title, Gut and Liver, and the URL https://www.gutnliver.organd MUST include a copy of the copyright notice. If an original work is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated For any commercial use of material from the open access version of the journal, permission MUST be obtained from Gut and Liver. Email: office@gutnliver.org
-
re-use by a non-author/third party/other publisher of parts of or all of an article or articles in another publication (journal or book) to be sold for commercial purposes
- the proactive supply of multiple print or electronic copies of items taken from the Journal to third parties on a systematic basis for marketing purposes
- re-use by an author of parts of or all of an article in other publications from commercial organizations
CrossMark is a multi-publisher initiative to provide a standard way for readers to locate the current version of a piece of content.
By applying the CrossMark logo, Gut and Liver (Gut and Liver), a CrossRef sponsoring member publisher for major Korean medical journals) is committing to maintaining the content it publishes and to alerting readers to changes if and when they occur.
Clicking on the CrossMark logo will tell you the current status of a document and may also give you additional publication record information about the document.
Gut and Liver deposits all published content in Similarity Check, a multi-publisher initiative started by CrossRef to help scientific publishers actively engage in efforts to prevent scholarly and professional plagiarism. Similarity Check is distinct from other plagiarism screening tools with its continuously growing database of current and archival scholarly literature. Wherever you see the "Similarity Check" logo, you can be reassured that the publisher whose content you are reading deposits into Similarity Check and is committed to publishing original research. To find out more about Similarity Check, visit